Clinical Application of Aminoglycosides

References

• Bendush C. L., Weber R. Tobramycin sulfate: a summary of worldwide experience from clinical trials. Journal of Infectious Diseases, Supplement 1976; 134: 219–234
   Google Scholar
• Brummet R. E., Fox K. E., Brown R. T., Hines D. L. Comparative ototoxic liability of netilmicin and gentamicin. Archives of Otolaryngology 1978; 104: 579–584
   PubMed Web of Science ®Google Scholar
• Curie K., Speller D. C. E., Simpson R. A., Stephens M., Cooke D. I. A. A Hospital Epidemic caused by Gentamicin resistant. Klebsiella aerogenes. Journal of Hygiene (Cambridge) 1978; 80: 115–123
   PubMedGoogle Scholar
• Dahlager J. I. Round table discussion on gentamicin and tobramycin. ‘Nephrotoxicity of gentamicin and tobramycin in animal models’. Royal Society of Medicine: International Congress and Symposium Series, No. 4, 1978; 29–35
   Google Scholar
• Dahlager J. I. The effect of netilmicin and other aminoglycosides on renal function. Scandinavian Journal of Infectious Diseases, Supplement 1980; 23: 96–102
   PubMedGoogle Scholar
• Dahlager J. I., Kahlmeter G. 1979; 99, quoted in Dahlager, J. I. (1980)
   Google Scholar
• Denneberg T., Haeger K., Juhlin I. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function. Scandinavian Journal of Infectious Diseases, Supplement 1980; 23: 135–140
   PubMedGoogle Scholar
• EORTC International Antimicrobial Therapy Project Group, Gaya H., et al. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 1978; 137: 14–29
   PubMed Web of Science ®Google Scholar
• Federspil P. J. Evaluation of the ototoxicity of netilmicin. Current Chemotherapy: Proceedings of the 10th International Congress of Chemotherapy. 1978; 2: 975–976
   Google Scholar
• Herting R. L., Lorber R. R., Miller M., Danzig M. R. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Arzneim-Forsch/Drug Research 1981; 31: 366–370
   PubMed Web of Science ®Google Scholar
• Hewitt W. L. Gentamicin: toxicity in perspective. Postgraduate Medical Journal 1974; 50(Supplement 7)55–59
   PubMedGoogle Scholar
• Jackson G. G., Arcieri G. Ototoxicity of gentamicin in man: A survey and controlled analysis of clinical experience in the USA. Journal of Infectious Diseases, Supplement 1971; 124: 130–137
   PubMed Web of Science ®Google Scholar
• Jao R. L., Jackson G. G. Gentamicin sulphate new antibiotic against Gram negative bacilli. Journal of the American Medical Association 1964; 189: 817–822
   PubMed Web of Science ®Google Scholar
• Keaney M., Caister H., Bax R., Noone P. Clinical experience with cefotaxime in hospitalized patients. Journal of Antimicrobial Chemotherapy 1982; 9: 313–318
   PubMed Web of Science ®Google Scholar
• Keys T. F., Kurtz S. B., Jones J. D. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans 1980, Abstract 547
   Google Scholar
• Liss R. H., Letourneau R. J. International round table discussion on sisomicin. Radiochemical and ultrastructural studies of sisomicin and gentamicin uptake by bacterial cells. Royal Society of Medicine: International Congress and Symposium Series, No. 35, 1980; 19–27
   Google Scholar
• Martin C. M., Cuomo A. J., Geraghty M. J., Zager J. R., Mandes T. C. Gram negative rod bacteraemia. Journal of Infectious Diseases 1969; 119: 506–517
   PubMed Web of Science ®Google Scholar
• Miller G. H., Hare R. S., Moss E. L., Sabatelli F. J., Waitz J. A. Microbiological studies with netilmicin. Clinical Trials Journal 1980; 17: 242–267
   Google Scholar
• Noone P. Round table discussion on gentamicin and tobramycin. ‘Personal experience with aminoglycosides’. Royal Society of Medicine: International Congress and Symposium Series, No. 4, 1978; 55–62
   Google Scholar
• Noone P., Pattison J. R., Davies D. G. The effective use of gentamicin in life-threatening sepsis. Post Graduate Medical Journal 1974; 50(Supplement 7)9–16
   PubMedGoogle Scholar
• Noone P., Perera M. R., Amirak I. D. International round table discussion on sisomicin. ‘Sisomicin in serious gram negative sepsis’. Royal Society of Medicine: International Congress and Symposium Series No. 35, 1980; 39–50
   Google Scholar
• Noone P., Rogers B. T. Pneumonia caused by coliforms and P. aeruginosa. Journal of Clinical Pathology 1976; 29: 652–656
   PubMed Web of Science ®Google Scholar
• Perera M. R., Amirak I. D., Noone P. High dose netilmicin in patients with life threatening sepsis. Journal of Antimicrobial Chemotherapy 1982; 9: 231–237
   PubMed Web of Science ®Google Scholar
• Riff L. J., Jackson G. G. Pharmacology of gentamicin in man. Journal of Infectious Diseases 1971; 124: S98–105
   PubMed Web of Science ®Google Scholar
• Schieker K. R., Hofman H. F. Prospective double blind controlled clinical study of sisomicin versus tobramycin. Pharmatherapeutica 1981; 2: 499–503
   PubMedGoogle Scholar
• Smith C. R., Lipsky J. J., Lasky O. L., Hellmann P. B., Mellits E. D., Longstreth J., Lietman P. S. Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin & tobramycin. New England Journal of Medicine 1980; 302: 1106–1109
   PubMed Web of Science ®Google Scholar
• Strausbaugh L. J., Mandaleris C. D., Sande M. A. J. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis. Journal of Laboratory Clinical Medicine 1977; 89: 692–701
   PubMed Web of Science ®Google Scholar
• Tjernström O. Prospective evaluation of vestibular and auditory function in 76 patients treated with netilmicin. Scandinavian Journal of Infectious Diseases, Supplement 1980; 23: 122–125
   PubMedGoogle Scholar
• Vesterhauge S., Johnsen N. J., Thomsen J., Svare J. Netilmicin treatment followed by monitoring of vestibular and auditory function using highly sensitive methods. Scandinavian Journal of Infectious Diseases, Supplement 1980; 23: 117–121
   PubMedGoogle Scholar
• Waitz J. A., Moss E. L., Jr., Drube E. G., Weinstein M. J. Comparative activity of sisomicin, gentamicin, kanamycin and tobramycin. Antimicrobial Agents and Chemotherapy 1972; 2: 431–437
   PubMed Web of Science ®Google Scholar